| VIVAX | VMVLX | VIVAX / VMVLX | |
| Total Expense Ratio | 0.17 | 0.06 | 283% |
| Annual Report Gross Expense Ratio | 0.17 | 0.06 | 283% |
| Fund Existence | 33 years | 18 years | - |
| Gain YTD | 11.965 | 12.284 | 97% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 3000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 208B | 10.4B | 2,000% |
| Annual Yield % from dividends | 1.98 | 2.04 | 97% |
| Returns for 1 year | 6.68 | 7.20 | 93% |
| Returns for 3 years | 33.49 | 35.18 | 95% |
| Returns for 5 years | 66.34 | 68.20 | 97% |
| Returns for 10 years | 135.00 | 140.09 | 96% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AIS | 38.67 | 0.06 | +0.17% |
| VistaShares Artificial Intelligence Supercycle ETF | |||
| CLSE | 27.14 | 0.03 | +0.11% |
| Convergence Long/Short Equity ETF | |||
| SPUT | 27.32 | 0.02 | +0.08% |
| Innovator Eq Prm Inc -Daily PutWrite ETF | |||
| GNOM | 44.07 | -0.03 | -0.07% |
| Global X Genomics & Biotechnology ETF | |||
| VTEI | 100.86 | -0.15 | -0.15% |
| Vanguard Intermediate-Term Tx-Exm Bd ETF | |||